Michiel Van De Sande

ResearcherPublications, citations & collaboration network

Michiel Van De Sande is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Michiel Van De Sande have?

ScholarIQindexed works

Michiel Van De Sande has 5 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Michiel Van De Sande →

How many citations does Michiel Van De Sande have?

ScholarIQcitation count

Michiel Van De Sande has 0 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Michiel Van De Sande →

What is the h-index of Michiel Van De Sande?

ScholarIQh-index

Michiel Van De Sande has an h-index of 0 in OpenAlex.

Open the OpenAlex record →

What is the i10-index of Michiel Van De Sande?

ScholarIQi10-index

Michiel Van De Sande has an i10-index of 0 in OpenAlex.

Open the OpenAlex record →

What is the OpenAlex record for Michiel Van De Sande?

ScholarIQopenalex

The OpenAlex for Michiel Van De Sande is on the source record.

Open the OpenAlex →

What are the most-cited papers on Michiel Van De Sande?

ScholarIQmost cited works

Mixed-Methods to Define Meaningful Change using Exit Interview and Clinical Trial Data in Patients with Tenosynovial Giant Cell Tumor (TGCT)

Heather L. Gelhorn, Katelyn N. Cutts, Brooke Harrow, Christopher Tait, Amanda Saunders, Tsion Fikre, Yipin Han, Nicholas A. Zeringo, Michiel Van De Sande, William Tap, Hans Gelderblom, Nicholas Bernthal

Quality of Life Research. 20260 CitationsOPEN ACCESS

Correction: Mixed-Methods to Define Meaningful Change using Exit Interview and Clinical Trial Data in Patients with Tenosynovial Giant Cell Tumor (TGCT)

Quality of Life Research. 20260 CitationsOPEN ACCESS

A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

Lee Jeys, Eduardo Botello, Richard Boyle, Walid Ebeid, Thomas Hilton, Matthew T. Houdek, Keith Hosking, Vineet Kurisunkal, Maritz Laubscher, Guy Morris, Ajay Puri, Pietro Ruggieri, Minna Laitinen, Yunus Abdul Bari, Ahmed Abood, John A. Abraham, Marthelena Acosta Marín, Manish Agarwal, Rishi Agarwal, Marcela Aguirre, Vivek Ajit Singh, T. Akiyama, Humaid Al Farii, Motaz AlAqeel, Abdulrahman Alaseem, OMAR ALDOSARI, Kate Alexander, Patricio Alfaro, Wazzan AlJuhani, Daniel C. Allison, Mohammed Almashahedi, Abdullah Alotaibi, Buğra Alpan, Ibrahim Alshaygy, Turki Althunayan, Lorenzo Andreani, Dimosthenis Andreou, Andriandi Andriandi, Lucas Annabelle, Luis Aponte-Tinao, Melanie Ardelt, Selma Armas, William Aston, Osman Emre Aycan, Thomas Baad-Hansen, Pablo Baeza, Charles Baird, Tessa Balach, Xavier Banse, Juan Barriga, Janie Barry, Georges Basile, Stefano Bastoni, Mohammad Hardian Basuki, Henrik C Bauer, Semay Baydar, Lee Bayliss, Ricardo Becker, Angad Bedi, Joseph Benevenia, Francisco Bengoa, Christina Berger, Nicholas Bernthal, Odion Binitie, Justin Bird, Abdulrahman Bobseit, Caitlin Bodian, Michele Boffano, Patricia Bonilla Huertas, Jos Bramer, Matthew Broadhead, Demiën Broekhuis, Samuel E. Broida, Delmer Brown, Alessandro Bruschi, T. B. Budny, Mirka Buist, Zachary Burke, Tilmann Busse, Jorge Cabrolier, José Antonio Calvo-Haro, Domenico Andrea Campanacci, Rodrigo Cardoso, Richard Carey Smith, María G. Carrasco, Nicolás Casales, Ashley Castan, Oscar Ceballos, Chung Ming Chan, Lester Chan, Liang Zhen Chang, Chris Charoenlap, Juan Fernando Chaustre Florez, Janet Chin, Peter Choong, Adam Chrobok, Yang‐Guk Chung, Dawid Ciechanowicz, M A Clara-Altamirano, Luis Alfonso Consuegra Guzman

PubMed. 20260 CitationsOPEN ACCESS

TANGENT study design: a phase III, randomized study of emactuzumab for the treatment of tenosynovial giant cell tumors

Hans Gelderblom, Emanuela Palmerini, Michiel Van De Sande, Javier Martin-Broto, Gabriel Tinoco, Elyse Seltzer, Madhu Davies, Ruth Coll, Sander Veltkamp, Jean-Yves Blay

Figshare. 20260 CitationsOPEN ACCESS